Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in ALLO — Allogene Therapeutics, Inc.

CIK 1000275 TORONTO, A6
Back to ALLO Full portfolio

Position in ALLO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$387,767
+$249,829 QoQ
Shares Held
186,427
+229.8% QoQ
Ownership
0.054%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#82
of 209 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 99% Shared 1% None 0%

Common Shares in ALLO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,118,794,122 across 427 Biotechnology names. ALLO ranks #87 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IONS
Ionis Pharmaceuticals Inc
 6,182,479 $490,208,754
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 980,259 $486,924,048
3 ALNY
Alnylam Pharmaceuticals, Inc.
 875,859 $263,659,830
4 INCY
Incyte Corp
 1,132,050 $128,329,182
5 REGN
Regeneron Pharmaceuticals, Inc.
 174,515 $108,817,078
6 MRNA
Moderna, Inc.
 944,457 $66,140,319
7 INSM
INSMED Inc
 416,487 $44,405,840
8 HALO
Halozyme Therapeutics, Inc.
 545,761 $42,716,712

All Filings in ALLO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $387,767 186,427
2026-03-31 $137,938 56,532
2025-12-31 $66,846 48,794
2025-09-30 $1,362,222 1,098,569
2025-06-30 $1,114,517 986,300
2025-03-31 $78,636 53,861
2024-12-31 $71,908 33,760
2024-09-30 $89,854 32,091
2024-06-30 $67,601 29,014
2024-03-31 $199,900 44,721
2023-12-31 $201,615 62,809
2023-09-30 $178,935 56,447
2023-06-30 $243,399 48,974
2023-03-31 $221,656 44,870
2022-12-31 $263,600 41,908
2022-09-30 $467,682 43,304
2022-06-30 $495,785 43,490
2022-03-31 $427,430 46,919
2021-12-31 $969,573 64,985
2021-09-30 $2,416,748 94,037
2021-06-30 $2,427,159 93,066
2021-03-31 $3,204,919 90,791
2020-12-31 $1,086,201 43,035
2020-09-30 $1,554,442 41,221
2020-06-30 $2,320,499 54,192
2020-03-31 $744,493 38,297